nivolumab,ipilimumab
ono Pharmaceuticals,bms
['nivo', 'checkmate 358']
updated results of checkmate 358 (nivo +/- ipi) in r current cervical cancer also shows great results especially in 1st-2nd line with 26% orr for monotherapy and 31-38% in combo arm -&gt; towards chemo-free regimen for cervix cancer #esmo22 
Medical oncologist - Drug development Department (DITEP) / Interception program for cancer prevention - Gustave Roussy Cancer Center 

Cooking aficionado =)